Citadel Advisors - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V909. A total of 3 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2016$515,000
-65.6%
39,800
-57.5%
0.00%
-50.0%
Q1 2016$1,497,000
-2.6%
93,600
+74.3%
0.00%0.0%
Q4 2015$1,537,000
+140.2%
53,700
+138.7%
0.00%
+100.0%
Q3 2015$640,000
-61.4%
22,500
-51.3%
0.00%0.0%
Q2 2015$1,660,000
+18.0%
46,200
+90.9%
0.00%0.0%
Q1 2015$1,407,000
-16.2%
24,200
-39.2%
0.00%
-50.0%
Q4 2014$1,678,000
-17.9%
39,800
-24.5%
0.00%0.0%
Q3 2014$2,044,000
+619.7%
52,700
+479.1%
0.00%
Q2 2014$284,0009,1000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 151,700$5,449,0000.08%
SIMPLEX TRADING, LLC 90$95,0000.01%
Citadel Advisors 46,200$1,660,0000.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders